Effects of sedative antidepressants on prefrontal cortex activity during verbal fluency task in healthy subjects: a near-infrared spectroscopy study.
BACKGROUND
Japanese researchers have recently conducted studies using near-infrared spectroscopy (NIRS) to help diagnose psychiatric disorders based on changes in brain activity. However, the influence of psychotropic drugs on NIRS measurements has not been clarified.


OBJECTIVE
To assess the effects of sedative antidepressants on prefrontal cortex activity in healthy subjects using NIRS in a double-blinded, placebo-controlled, crossover trial.


METHODS
Nineteen healthy males received nocturnal doses of mirtazapine 15 mg, trazodone 25 mg, or placebo for eight consecutive days in rotation, with a washout period of more than 1 week between each rotation. Subjects performed a verbal fluency task during NIRS on a total of seven occasions during the study period: more than a week prior to receiving the first dose of the first medication; and on days 2 and 9 of each rotation. The number of words correctly generated during the task (behavioral performance) was also recorded. Stanford Sleepiness Scale (SSS) scores were determined each day.


RESULTS
Mirtazapine 15 mg significantly increased oxyhemoglobin (oxy-Hb) concentration change in NIRS on day 9, compared to trazodone 25 mg and placebo. Mirtazapine 15 mg significantly increased SSS on day 2, compared to the other conditions. No significant differences in behavioral performance were observed.


CONCLUSIONS
Administration of mirtazapine for eight consecutive days affected oxy-Hb changes on NIRS. This result indicates that researchers should consider how certain types of antidepressant could influence brain function when the brain activity of patients with psychiatric disorders is assessed.
Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Showa, Nagoya, Aichi, Japan.
Kunihiro
K
Kohmura
Kunihiro
K
Iwamoto
Branko
B
Aleksic
Kazumi
K
Sasada
Naoko
N
Kawano
Hiroto
H
Katayama
Yukihiro
Y
Noda
Akiko
A
Noda
Tetsuya
T
Iidaka
Norio
N
Ozaki
D000328:Adult; D000704:Analysis of Variance; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D059907:Functional Neuroimaging; D006801:Humans; D008297:Male; D008803:Mianserin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D008875:Middle Aged; D000078785:Mirtazapine; D010108:Oxyhemoglobins / Q000032:analysis; D017397:Prefrontal Cortex / Q000187:drug effects* / Q000502:physiology; D012890:Sleep / Q000187:drug effects*; D019265:Spectroscopy, Near-Infrared / Q000379:methods; D013068:Speech Production Measurement; D013647:Task Performance and Analysis; D014196:Trazodone / Q000008:administration & dosage / Q000009:adverse effects
D000928:Antidepressive Agents; D010108:Oxyhemoglobins; D008803:Mianserin; D000078785:Mirtazapine; D014196:Trazodone